CJC-1295 / Ipamorelin – 5mg / 5mg
$100.00
CJC-1295 / Ipamorelin Blend
The CJC-1295 / Ipamorelin blend combines two potent peptides known for their ability to stimulate growth hormone release. CJC-1295 enhances the release of growth hormone by acting on the pituitary gland, while Ipamorelin works synergistically by mimicking ghrelin, which further stimulates the secretion of growth hormone. This combination is of interest in research for its potential to promote muscle growth, fat metabolism, and overall recovery while providing a more balanced, sustained release of growth hormone.
Potential Research Applications
The CJC-1295 / Ipamorelin blend is currently being explored in research settings for its role in:
- Growth Hormone Stimulation: Investigated for its combined effect in stimulating consistent growth hormone release, which may enhance muscle growth and tissue repair.
- Muscle & Fat Metabolism: Studied for its potential to promote lean muscle mass development and reduce body fat.
- Recovery & Regeneration: Researched for its potential to support faster recovery and tissue regeneration following injury or stress.
- Anti-Aging & Cellular Health: Explored for its potential benefits in slowing down aging processes through enhanced regeneration and metabolic health.
✔ High-Quality Research Peptide – Produced under stringent quality control standards.
✔ Lab-Tested for Purity – Ensures consistency for scientific studies.
✔ Research Use Only – Not for human consumption or medical applications.
✔ Peptides – Will arrive in a lyophilized (powder) form for maximum stability.
The peptides are available for research and laboratory purposes only. Please review and ahere to our Terms and Conditions before ordering.
- Description
- Certificate of Analysis
The combination of CJC-1295 and Ipamorelin has gained attention for stimulating growth hormone (GH) release through complementary mechanisms. CJC-1295, a synthetic analog of growth hormone-releasing hormone (GHRH), enhances the pulsatile release of GH, closely mimicking the body’s natural secretion patterns. In contrast, Ipamorelin, a selective ghrelin mimetic and growth hormone secretagogue, amplifies GH release while minimizing unwanted side effects typically seen with other secretagogues.
Together, this blend shows synergistic effects on GH secretion. CJC-1295 initiates the release process, while Ipamorelin enhances GH pulses. Unlike other GH-releasing compounds, Ipamorelin selectively avoids significant elevations in cortisol or prolactin levels. Researchers have explored this combination in studies related to protein synthesis, cellular repair, and metabolic efficiency. They have specifically focused on its effects on lipolysis and lean tissue preservation.
Additionally, the interaction between these peptides has become a key focus. Their combined action leads to a more robust, yet physiologically regulated, GH response. Studies examine their roles in optimizing recovery, cellular regeneration, and metabolic homeostasis. Due to their distinct mechanisms of action, this blend continues to attract interest in GH modulation research.
For Research Use Only
No Certificate of Analysis images available for this product.
